Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer
Clinical trial NCT02390934 · COMPLETED
Trial details
- NCT number
- NCT02390934
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2019-04-02
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.